(Q34416456)

2 August 2017

1 reference

title

Life-threatening adverse events of antiepileptic drugs (English)

1 reference

2 August 2017

Arroyo S

1

1 reference

2 August 2017

de la Morena A

series ordinal

2

1 reference

2 August 2017

publication date

1 November 2001

1 reference

2 August 2017

1 reference

2 August 2017

volume

47

1 reference

2 August 2017

issue

1-2

1 reference

2 August 2017

page(s)

155-174

1 reference

Hematologic toxicity of sodium valproate

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Absence of bleeding complications in patients undergoing cortical surgery while receiving valproate treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Epilepsy, vagal nerve stimulation by the NCP system, mortality, and sudden, unexpected, unexplained death

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Acute hepatic failure in a child treated with lamotrigine

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Valproate-associated pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders with distinct causes

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Safety and efficacy of divalproex sodium monotherapy in partial epilepsy: a double-blind, concentration-response design clinical trial. Depakote Monotherapy for Partial Seizures Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Association of intravenous phenytoin toxicity with demographic, clinical, and dosing parameters

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Topiramate and fulminant liver failure

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Cardiac conduction disturbances during carbamazepine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Taming the brain storms: felbamate updated

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Valproic acid hepatic fatalities. III. U.S. experience since 1986.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Pancreatitis due to valproic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Efficacy of felbamate in therapy for partial epilepsy in children.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: a multicentre randomised double-blind study. Vigabatrin European Monotherapy Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Serum anticonvulsant concentrations and the risk of drug induced skin eruptions

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Plasmapheresis in toxic epidermal necrolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Dilantin sensitivity; report of a case of hepatitis with jaundice, pyrexia and exfoliative dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Cutaneous reactions to anticonvulsants

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Multiorgan dysfunction and disseminated intravascular coagulation in children receiving lamotrigine and valproic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Sino-atrial block provoked by carbamazepine

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Long-term evaluation of vigabatrin (gamma vinyl GABA) in epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

l-Carnitine Supplementation in Childhood Epilepsy: Current Perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Thrombocytopenia secondary to high valproate levels in children with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Skin eruption with gabapentin in a patient with repeated AED-induced Stevens-Johnson's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Felbamate in the treatment of Lennox-Gastaut syndrome: results of a 12-month open-label study following a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Phenytoin administration by constant intravenous infusion: selective rates of administration

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Hepatic considerations in the use of antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Valproic acid hepatic fatalities. II. US experience since 1984.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Valproic acid hepatic fatalities: a retrospective review

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Cardiac side effects of phenytoin and carbamazepine. A dose-related phenomenon?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Reversal of erythema multiforme major with cyclophosphamide and prednisone

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Anemia associated with lamotrigine

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Potential hepatotoxicity of lamotrigine

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Population-based study of the incidence of sudden unexplained death in epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Practice advisory: The use of felbamate in the treatment of patients with intractable epilepsy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Familial occurrence of hypersensitivity to phenytoin

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Idiosyncratic reactions: new methods of identifying high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Gabapentin induced polyneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Investigation of metabolic disorders resembling Reye's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Acute management of hypersensitivity reactions and seizures.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Lamotrigine-associated rash: risk/benefit considerations in adults and children

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Sudden infant death syndrome and inherited disorders of fatty acid beta-oxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Carbamazepine and hematological monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Phenytoin hypersensitivity: 38 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Hepatotoxic reactions associated with carbamazepine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Cross sensitivity of skin rashes with antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Carbamazepine-induced cardiac dysfunction. Characterization of two distinct clinical syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Evaluation of case reports of aplastic anemia among patients treated with felbamate

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Epidemiological assessment of drug-induced disease

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Carbamazepine induced bradycardia--a problem in general or only in susceptible patients? A 24-h long-term electrocardiogram study

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Bronchiolitis obliterans in children with Stevens-Johnson syndrome: follow-up with high resolution CT.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Valproate treatment and platelet function: the role of arachidonate metabolites.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Anticonvulsant hypersensitivity syndrome: incidence, prevention and management

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Fatal liver failure associated with valproate therapy in a patient with Friedreich's disease: review of valproate hepatotoxicity in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Severe hepatotoxicity during valproate therapy: an update and report of eight new fatalities.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Valproate therapy induces von Willebrand disease type I

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Carbamazepine-induced acute cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Mechanisms of idiosyncratic hypersensitivity reactions to antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Safety of long-term lamotrigine in epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Efficacy and adverse effects of established and new antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Safety review of adult clinical trial experience with lamotrigine

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Frequency-independent blockade of cardiac Na+ channels by riluzole: comparison with established anticonvulsants and class I anti-arrhythmics

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Treatment of Stevens-Johnson syndrome with pooled human intravenous immune globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Hepatic injury associated with diphenylhydantoin therapy. A clinicopathologic study of 20 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Suppression of carbamazepine-induced rash with prednisone

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Enhanced differential diagnosis of anticonvulsant hypersensitivity reactions by an integrated Bayesian and biochemical approach.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

EKG abnormalities during partial seizures in refractory epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Thrombocytopenia in association with adjunctive felbamate use.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Leucopenia associated with lamotrigine

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Risk factors for sudden unexpected death in epilepsy: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Comparison of antiepileptic drug levels in sudden unexpected deaths in epilepsy with deaths from other causes

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Pancreatitis with normal serum amylase associated with sodium valproate: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Allergic Rash Due to Antiepileptic Drugs: Clinical Features and Management

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Carbamazepine side effects in children and adults

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

1 reference

7 January 2021

Felbamate in epilepsy therapy: evaluating the risks

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Felbamate: 1997 update

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

A rational guide to routine blood monitoring in patients receiving antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Mortality in antiepileptic drug development programs

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Cutaneous Reactions in Head-injured Patients Receiving Phenytoin for Seizure Prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Drug-induced toxic epidermal necrolysis treated with cyclosporin.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Cytochrome P-450--catalyzed formation of delta 4-VPA, a toxic metabolite of valproic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Toxic epidermal necrolysis (Lyell syndrome). Incidence and drug etiology in France, 1981-1985

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Severe adverse cutaneous reactions to drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Risk of Stevens-Johnson syndrome and toxic epider mal necrolysis during first weeks of antiepileptic therapy: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Lamotrigine-induced Stevens-Johnson syndrome: demonstration of specific lymphocyte reactivity in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Lamotrigine-induced severe cutaneous adverse reactions.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Antiepileptic drug hypersensitivity syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Adverse effects of valproate.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Toxic epidermal necrolysis and Stevens-Johnson syndrome. An epidemiologic study from West Germany

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Phenytoin hypersensitivity reaction presenting with toxic epidermal necrolysis and severe hepatitis. Report of a patient treated with corticosteroid "pulse therapy"

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Hematological monitoring during therapy with carbamazepine in children

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Sodium valproate and bone marrow suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

A possible case of carbamazepine-induced pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

A population-based study of Stevens-Johnson syndrome. Incidence and antecedent drug exposures

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: a record linkage study

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Valproate metabolites and hepatotoxicity in an epileptic population

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Intraoperative defect in haemostasis in a child receiving valproic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Identification of modified atropaldehyde mercapturic acids in rat and human urine after felbamate administration

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Necrotizing Pancreatitis After 10 Years of Therapy with Valproic Acid

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Allergy to carbamazepine: parallel in vivo and in vitro detection

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Adjunctive gabapentin treatment of bipolar disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Incidence and risk factors in sudden unexpected death in epilepsy: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

A comparative review of the adverse effects of anticonvulsants in children with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Valproic acid-induced cytopenias: evidence for a dose-related suppression of hematopoiesis

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Carbamazepine-induced heart block in a child with tuberous sclerosis and cardiac rhabdomyoma: implications for evaluation and follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Toxic epidermal necrolysis. Granulocytic leukopenia as a prognostic indicator

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Pediatric use of intravenous and intramuscular phenytoin: lessons learned

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Zonisamide in epilepsy: a pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Oculocutaneous Manifestations of the Erythema Multiforme/Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Spectrum

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Possible drug-induced thrombocytopenia secondary to tiagabine

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

High incidence of a concentration-dependent skin reaction in children treated with phenytoin

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Factors Influencing the Incidence of Lamotrigine-Related Skin Rash

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Making medicines safer--the need for an independent drug safety board.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

In vitro lymphocyte proliferation by carbamazepine, carbamazepine-10, 11-epoxide, and oxcarbazepine in the diagnosis of drug-induced hypersensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Influence of valproate monotherapy on platelet activation and hematologic values

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

Valproate-induced hepatic injury: analyses of 23 fatal cases

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900306-0

7 January 2021

10.1016/S0920-1211(01)00306-0

Identifiers

DOI

1 reference

2 August 2017

1 reference